XML 24 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements Income and Comprehensive Income - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:      
Revenues $ 1,887.1 $ 1,488.7 $ 1,133.5
Operating expenses:      
Cost of revenues 39.7 23.2 14.3
Research and development 565.0 463.8 328.1
Acquired in-process research and development 143.9 0.0 105.3
Selling, general and administrative 887.6 752.7 583.3
Total operating expenses 1,636.2 1,239.7 1,031.0
Operating income 250.9 249.0 102.5
Other income (expense):      
Interest expense (4.6) (7.1) (25.8)
Unrealized gain on equity securities 28.4 30.8 20.9
Loss on extinguishment of convertible senior notes 0.0 (70.0) 0.0
Investment income and other, net 57.4 11.2 3.8
Total other income (expense), net 81.2 (35.1) (1.1)
Income before provision for income taxes 332.1 213.9 101.4
Provision for income taxes 82.4 59.4 11.8
Net income 249.7 154.5 89.6
Foreign currency translation adjustments, net of tax 2.4 2.9 0.0
Unrealized gain (loss) on debt securities available-for-sale, net of tax 12.5 (9.1) (3.5)
Comprehensive income $ 264.6 $ 148.3 $ 86.1
Earnings per share, basic (in USD per share) $ 2.56 $ 1.61 $ 0.95
Earnings per share, diluted (in USD per share) $ 2.47 $ 1.56 $ 0.92
Weighted average common shares outstanding, basic (in shares) 97.7 95.8 94.6
Weighted average common shares outstanding, diluted (in shares) 101.0 98.9 97.9
Net product sales      
Revenues:      
Revenues $ 1,860.6 $ 1,440.9 $ 1,090.1
Collaboration revenue      
Revenues:      
Revenues $ 26.5 $ 47.8 $ 43.4